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There is a strong link between high fat intake and obesity. In addition to 
its high caloric density, dietary fat has a hyperphagic effect, in part as a 
result of its high palatability. The recent identification by Laugerette et al. 
of CD36 as a taste receptor for fatty acids provides insight into the molec-
ular basis of our preference for fat (see the related article beginning on 
page 3177). As we gain more information regarding the function of this 
receptor, we may be able to devise better strategies to address the addictive 
potential of dietary fat.
The eighteenth-century French philoso-
pher Charles De Montesquieu once com-
mented, “Lunch kills half of Paris, sup-
per the other half.” The potential of food 
consumption to lead to serious health 
complications is well known and has been 
extensively studied. The last decade has 
witnessed impressive progress related to 
some of the molecular mechanisms under-
lying the development of nutrition-related 
pathologies such as obesity, type 2 diabe-
tes, and cardiovascular disease. Informa-
tion on interorgan cross-talk, on various 
adipokines and myokines, and on proteins 
involved in controlling energy intake, stor-
age, or expenditure has greatly enhanced 
our insight into how the body maintains 
homeostasis (1, 2). Dysfunction within 1 or 
more homeostatic mechanisms can occur 
as a result of complex interactions between 
genetic predisposition and today’s afflu-
ent lifestyle, often leading to serious health 
consequences. This has been highlighted 
by numerous studies of genetically altered 
animals and by the identification of poly-
morphisms in humans (3–5).
A potential new frontier in nutrition 
research is the examination of how the 
orosensory experience of food can impact 
food intake and processing as well as the 
development of long-term addictive pat-
terns. In addition to food abundance, 
current enhancements in food palatabil-
ity through high sugar or fat content fur-
ther challenge our ability to control food 
intake and maintain body weight homeo-
stasis. The sensory experience of food can 
be a primary reinforcer of intake. To what 
extent food perception is determined by 
genes versus the environment is a topic 
that has received limited attention. There 
is evidence that obesity may be associated 
with an abnormal brain response to the 
sensory perception of a meal. This abnor-
mal response may even persist in post-
obese individuals, creating a high risk of 
relapse (6). There is little doubt that as 
individuals, we greatly differ in our abil-
ity to experience food at the basic level of 
taste. According to the NIH, approximately 
25% of Americans are nontasters, 50% are 
medium tasters, and 25% are supertasters. 
So what are the factors that contribute 
to determining our food perception, and 
how are they reflected in what we choose 
to eat and how much? These questions are 
important, since our food choices greatly 
impact body weight outcome in terms of 
how big and how fast. Impressive progress 
has been recently accomplished in the iden-
tification of taste receptors for various sen-
sations such as sweet, salty, and bitter (7), 
and this is beginning to contribute insight 
into the interaction between heredity and 
the environment in determining food pref-
erences and intake patterns (8, 9).
8IZEPXFMJLFGBU 
An exciting new development is the iden-
tification of a taste receptor for fat that 
specifically recognizes fatty acids (FAs), as 
reported in this issue of the JCI by Lauger-
ette et al. (10). It seems a propos that the 
report is by a group of French researchers 
from the University of Bourgogne in Dijon, 
an area with a rich gastronomic tradition. 
Dietary fat is particularly addictive, and 
its excessive intake is strongly linked to 
obesity. Orosensory perception is thought 
to play an important role in the spontane-
ous preference for fat-rich food exhibited 
by humans and rodents. A hyperphagic 
effect of a diet with high fat content has 
been documented and is manifested in 
increased meal size and decreased inter-
meal interval (11). Postingestive effects 
of fat, which include feelings of content-
ment and satiety and possibly elevation 
in endogenous opiate levels, also promote 
long-term preference and positive rein-
forcement. These effects are not observed 
with equally palatable, but nondigestible, 
fat substitutes (12).
Existence of an orosensory receptor for 
FAs would necessitate a revision of cur-
rently held concepts related to food per-
ception. Textbooks still state that taste 
buds recognize 5 basic sensations; sweet, 
sour, bitter, salty, and umami (L–amino 
acid). Evidence presented in several earlier 
publications strongly suggested that the 
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list should be revised to include a recep-
tor for fat. In particular, 2 reports in 1997 
are worth noting, since they specifically 
implied involvement of FAs in gustation. 
Gilbertson et al. (13) reported that dietary 
fat may be sensed by taste cells via FA inhi-
bition of the delayed rectifying K+ chan-
nels. Fukuwatari et al. (14) documented 
apical expression of the membrane FA 
translocase CD36 in taste bud cells. How-
ever, the relevance of gustatory cues for 
FAs remained uncertain, since dietary 
fat is mostly present as triglycerides that 
have to be hydrolyzed by digestive lipases 
during absorption. Then in 2003, Kawai 
and Fushiki (15) asked whether the lipase 
present in the mouth (lingual lipase) func-
tioned to release free FAs for interaction 
with taste receptors. They reported the 
significant observation that addition of a 
lipase inhibitor diminished the spontane-
ous preference of rodents for triglycerides 
but not that for free FAs.
The work of Laugerette et al. (10), 
which uses CD36-null mice, provides 
compelling evidence to implicate CD36 
in oral fat perception and in trigger-
ing neural mechanisms that lead to bile 
secretion. The article nicely illustrates the 
physiological functions of taste recep-
tors. Although the sensory experience 
of fat can lead to serious food addiction 
and health problems, its intended role is 
to guide appropriate food selection and 
also to enhance digestion. The role of 
neural input from taste receptors in the 
digestive process was probably first dem-
onstrated in a study with subjects that 
failed to show absorption of vitamin A 
palmitate, which was published in the 
JCI in 1954 (16). The author of the study, 
Mendeloff, stated that, surprisingly, the 
thought or act of eating appeared to acti-
vate mechanisms that markedly increase 
fat absorption. His conclusion was based 
on the observation that sham feeding, 
which involved mastication of a palatable 
meal without swallowing any of it, was 
associated with an immediate increase in 
blood levels of vitamin A palmitate given 
2 hours earlier (16). Subsequent studies 
have extended these observations and 
further demonstrated that orosensation 
contributes to enhancing fat absorption 
and to a faster appearance of absorbed 
products in the blood (17).
5IFGBUNFTTFOHFS
CD36, the protein identified as a taste 
receptor for fat, is an integral membrane 
glycoprotein and a member of a family of 
proteins expressed both at the cell surface 
and within lysosomes. The class B scav-
enger receptor family includes the high-
density lipoprotein receptor scavenger 
receptor type B, class I (SR-BI; also known 
as CLA-1), which functions in selective 
cholesterol uptake from high-density lipo-
proteins. CD36 and SR-BI share a hairpin 
membrane topology (Figure 1) with 2 
transmembrane domains and with both 
termini in the cytoplasm (3, 18).
CD36 was identified as a facilitator of 
FA uptake by binding sulfosuccinimidyl 
oleate, a reactive oleic acid derivative and 
inhibitor of FA transport. The protein puri-
fied from rat adipose tissue was initially 
called FA translocase (FAT) and later iden-
tified to be the rat homolog of CD36 (19). 
Expression of CD36 favors tissues with 
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CD36-null mice have impaired FA uptake 
by muscle and adipose tissues and rely on 
glucose metabolism for energy, which is 
reflected by fasting hypoglycemia (3, 18). 
The mice exhibit poor performance in 
exercise tests, with compromised endur-
ance and recovery. The deficiency also 
alters the metabolic response to dietary 
nutrients. The mice have enhanced insulin 
sensitivity on a chow diet and are partially 
protected from the diabetogenic effects 
of high-fat diets, but are more susceptible 
to those diets high in simple sugars like 
fructose (3, 18). CD36 deficiency also has 
a protective effect against atherosclerosis 
promoted by apoE deficiency, probably 
reflecting a blunting of the inflammatory 
response (3, 19). At the level of the small 
intestine, CD36 deficiency is associated 
with defects in the secretion of chylomi-
crons into the lymph and in their clear-
ance from the blood (20).
Analogies can be made between the roles 
of CD36 in the taste bud and at the level 
of the whole organism. In both settings, 
FA interaction with CD36 contributes to 
transducing signals that alter lipid utiliza-
tion downstream. For example, our recent 
unpublished observations indicate that 
CD36-FA sensing in adipocytes has an 
impact on the secretion of adipokines such 
as leptin and adiponectin, which play an 
important role in organ cross-talk and in 
the regulation of energy expenditure from 
lipids. In turn, adipokines may accomplish 
some of their effects on lipid metabo-
lism via regulating CD36 levels. We also 
observed that CD36 function in FA uptake 
impacts expression and activity of PPARs, 
nuclear transcription factors that regu-
late genes of lipid metabolism (including 
CD36) in a tissue-specific fashion. In the 
small intestine, FA uptake via CD36 seems 
coupled to efficient chylomicron secretion 
into the lymph (20). In muscle it is coupled 
to FA oxidation.
Acute regulation of CD36 expression 
by relocalization is observed under situa-
tions where energy from lipids is needed. 
In muscle, contraction triggers CD36 
translocation to the membrane, which 
supplies oxidative energy to the working 
muscle (21). Translocation also occurs 
with fasting, triggered by activation of 
the forkhead transcription factor FOXO1 
(22). This enhances FA uptake and oxida-
tion as glucose availability is diminished 
and spares it for glucose-dependent tis-
sues. It will be interesting to determine 
whether translocation of CD36 also 
occurs in taste receptor cells in response 
to FAs and whether it contributes to sig-
nal transduction.
%FDPEJOHUIFNFTTBHF
How CD36 accomplishes its function in FA 
uptake or sensing is currently unknown, 
and so are the mechanisms likely to medi-
ate its role in transducing neural signals 
for bile acid secretion. In many cells, CD36 
has been shown to be associated with Src-
like tyrosine kinases (23). Binding to CD36 
may alter its dimerization state, leading 
to activation of Src kinases and to the ini-
tiation of signaling events. FA binding to 
CD36 has also been shown to activate NO 
synthase (24), and NO production has 
been implicated in the function of some 
taste receptors (7). For example, one could 
speculate that FAs alter the localization or 
dimerization state of CD36. Since CD36 is 
associated with membrane integrins, it is 
possible that such changes may result in 
membrane alterations that would perturb 
activity of neighboring K+ channels.
The identification of CD36 as a taste 
receptor for fat (10) is likely to have clini-
cal relevance. As more is learned about the 
specificity and mechanism of this receptor’s 
function, it may be possible to devise strate-
gies to treat some forms of obesity. As sug-
gested by many studies, taste dysfunctions 
— whether inherited or acquired — may be 
responsible for abnormalities in food intake, 
leading to obesity. These dysfunctions may 
not be reversed by weight loss, predisposing 
individuals to a relapse. It is not unreason-
able to suggest that polymorphisms in the 
CD36 gene (4) or environmentally induced 
changes in its expression levels or function 
may be responsible for some of the dysfunc-
tions in fat orosensation.
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